Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (NASDAQ: GDRX) is widely described as the leading platform for medication savings in the U.S., and its news flow reflects that role at the intersection of digital healthcare, pharmacy, and pharmaceutical manufacturers. Company announcements highlight new partnerships, product launches, and financial updates that shape how consumers, pharmacies, and manufacturers approach prescription affordability.
News about GoodRx often covers collaborations with major healthcare players. Examples include the RxSmartSaver program powered by GoodRx at national and regional retail pharmacies, which brings brand medication savings directly to the pharmacy counter, and an exclusive partnership with Surescripts that integrates GoodRx discounted cash prices into Script Corner, a patient experience product focused on prescription price transparency.
GoodRx also issues press releases on new consumer offerings and subscriptions. Recent updates describe GoodRx for Weight Loss, a telemedicine subscription for GLP-1 weight management treatment, and GoodRx for Hair Loss, a subscription program for men that combines virtual consultations, prescriptions for oral finasteride or oral minoxidil when appropriate, and discreet home delivery. Additional news highlights defined cash prices for medications such as Repatha, Ozempic, Wegovy, and the Wegovy pill at tens of thousands of pharmacies nationwide via GoodRx.
Investors and observers can also find earnings-related news, including quarterly financial results, guidance commentary, and participation in healthcare conferences. Together, these updates provide insight into GoodRx’s strategy across prescription transactions, subscriptions, pharma manufacturer solutions, and telehealth. For anyone tracking GDRX, this news page offers a focused view of how the company is evolving its platform, expanding partnerships, and addressing medication affordability across the U.S. healthcare system.
GoodRx Holdings, Inc. (Nasdaq: GDRX), a top digital healthcare platform, is set to present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on January 11, 2023, at 3:45 p.m. PT. A live webcast of this presentation will be available on the Company's Investor Relations website and will be archived for 30 days. GoodRx has saved consumers over $45 billion since its inception in 2011, providing affordable healthcare solutions to Americans.
GoodRx Holdings, Inc. (GDRX) has reported its third-quarter 2022 financial results, achieving total revenue of $187.3 million, which surpassed previous guidance despite a 4% year-over-year decline. The net loss was $41.7 million, reflecting a challenging environment, particularly from the grocer issue affecting prescription transactions revenue, which decreased 16% to $131.2 million. However, subscription revenue grew by 63% to $26.5 million. Adjusted EBITDA was reported at $52.0 million, a decrease from the prior year, with management anticipating fourth-quarter revenue guidance of $175-$180 million, factoring continued challenges.
GoodRx (NASDAQ: GDRX) released a report indicating that expanding pharmacist prescribing authority significantly enhances access to critical medications, especially for PrEP (HIV prevention pill). The report highlights an increase in PrEP fills by 24% after one year and 110% after two years in states that allow pharmacists to prescribe. Over 37 million Americans reside in under-resourced areas where pharmacist authority could enhance healthcare access. GoodRx emphasizes that improved access leads to better medication adherence, benefiting both patients and healthcare providers.
GoodRx Holdings, Inc. (Nasdaq: GDRX), a digital healthcare platform, will present at two upcoming investor conferences. The first is the Credit Suisse 31st Annual Healthcare Conference on November 10 in Rancho Palos Verdes, CA, at 9:50 a.m. Pacific Time. The second is the Wells Fargo 6th Annual TMT Summit on December 1 in Las Vegas, NV, at 8:40 a.m. Pacific Time. Live webcasts and archived recordings will be available on the Company's Investor Relations website. GoodRx has saved consumers over $40 billion since 2011 and is among the most downloaded medical apps in the past decade.
GoodRx has launched Provider Mode, a dedicated platform for healthcare providers aimed at reducing administrative workload while facilitating patient access to medications. Since June 2021, over 850,000 prescribers have utilized GoodRx for medication pricing and discounts. With a 90% net promoter score among providers, the tool offers features like cost comparison, a dashboard for easy access to resources, and savings programs. Additionally, partnerships with companies like Biogen enhance its offerings to streamline processes for specialty therapies.
GoodRx (NASDAQ: GDRX) has launched a new feature called Provider Mode, designed to streamline the enrollment process for healthcare providers (HCPs) prescribing VUMERITY® (diroximel fumarate) for relapsing multiple sclerosis. This digital form helps reduce paperwork and errors, significantly speeding up patient treatment initiation. Since its rollout, Provider Mode has achieved a 90% opt-in rate from providers, with Biogen (NASDAQ: BIIB) being the first pharmaceutical partner to use this system. This collaboration aims to enhance patient care by simplifying the therapy start process.
GoodRx Holdings Inc. (GDRX) will release its Q3 2022 financial results on November 8, 2022, after U.S. market close. A conference call and webcast are scheduled for the same day at 2:00 PM PT (5:00 PM ET) to discuss these results and provide business insights. GoodRx, a digital healthcare platform, has saved consumers over $40 billion since its launch in 2011. Investors can access the live call and archived materials on the Company’s investor relations website.
GoodRx (NASDAQ: GDRX) is offering free online healthcare provider visits to Florida residents affected by Hurricane Ian until October 17, using the code FL-CARE-100. This initiative aims to ensure residents can access essential healthcare services amidst the ongoing recovery challenges. GoodRx Care allows for consultations for various conditions and medication refills, aiding those impacted by the disaster. The platform is focused on making healthcare affordable and convenient, having saved consumers over $40 billion since its inception in 2011.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA, on Thursday, September 15, at 11:30 a.m. PT (2:30 p.m. ET). A live webcast will be available on the Company's Investor Relations website. GoodRx, a digital healthcare platform, has helped consumers save over $40 billion since 2011, providing affordable healthcare solutions. Archived recordings of the presentation will be accessible for at least 30 days post-conference.
Summary not available.